KR20090099075A - Ｆｏｘｐ３ 펩티드 백신 - Google Patents

Ｆｏｘｐ３ 펩티드 백신 Download PDF

Info

Publication number
KR20090099075A
KR20090099075A KR1020097015693A KR20097015693A KR20090099075A KR 20090099075 A KR20090099075 A KR 20090099075A KR 1020097015693 A KR1020097015693 A KR 1020097015693A KR 20097015693 A KR20097015693 A KR 20097015693A KR 20090099075 A KR20090099075 A KR 20090099075A
Authority
KR
South Korea
Prior art keywords
peptide
foxp3
seq
cells
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020097015693A
Other languages
English (en)
Korean (ko)
Inventor
타쿠야 츠노다
류지 오사와
Original Assignee
온코세라피 사이언스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온코세라피 사이언스 가부시키가이샤 filed Critical 온코세라피 사이언스 가부시키가이샤
Publication of KR20090099075A publication Critical patent/KR20090099075A/ko
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020097015693A 2007-01-03 2007-12-26 Ｆｏｘｐ３ 펩티드 백신 Abandoned KR20090099075A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87861507P 2007-01-03 2007-01-03
US60/878,615 2007-01-03
US89647207P 2007-03-22 2007-03-22
US60/896,472 2007-03-22

Publications (1)

Publication Number Publication Date
KR20090099075A true KR20090099075A (ko) 2009-09-21

Family

ID=39588270

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097015693A Abandoned KR20090099075A (ko) 2007-01-03 2007-12-26 Ｆｏｘｐ３ 펩티드 백신

Country Status (14)

Country Link
US (1) US8563516B2 (https=)
EP (2) EP2481748A3 (https=)
JP (1) JP5339375B2 (https=)
KR (1) KR20090099075A (https=)
CN (1) CN101641369B (https=)
AU (1) AU2007340834B2 (https=)
BR (1) BRPI0720794A2 (https=)
CA (1) CA2674365A1 (https=)
IL (1) IL199622A0 (https=)
MX (1) MX2009007261A (https=)
RU (1) RU2473557C2 (https=)
SG (1) SG177199A1 (https=)
TW (1) TWI441648B (https=)
WO (1) WO2008081581A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009050486A2 (en) * 2007-10-19 2009-04-23 The University Of Surrey Peptide manipulators of regulatory t cell activity
CZ301144B6 (cs) * 2008-09-15 2009-11-18 Vysoká škola chemicko technologická v Praze Príprava monoklonálních protilátek proti FoxP3 proteinu s použitím modifikovaných virum podobných cástic Masonova-Pfizerova opicího viru
WO2010073551A1 (en) * 2008-12-24 2010-07-01 Oncotherapy Science, Inc. C1orf59 peptides and vaccines including the same
TWI507204B (zh) * 2009-05-26 2015-11-11 Oncotherapy Science Inc Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
ES2647900T3 (es) * 2011-08-12 2017-12-27 Oncotherapy Science, Inc. Péptidos MPHOSPH1 y vacunas que incluyen los mismos
CN102603892B (zh) * 2012-02-22 2013-10-30 尉军 一种肿瘤标志物foxp3抗原多肽及应用
US11505599B2 (en) 2016-01-14 2022-11-22 Memorial Sloan-Kettering Cancer Center T cell receptor-like antibodies specific for Foxp3-derived peptides
CN111375055B (zh) * 2020-02-20 2021-09-03 陈宛莎 一种2019-nCoV亚单位疫苗组合物及其免疫方法
WO2025136809A2 (en) * 2023-12-19 2025-06-26 Regeneron Pharmaceuticals, Inc. Foxp3 peptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001831A1 (en) 1991-07-25 1993-02-04 Idec Pharmaceuticals Corporation Induction of cytotoxic t-lymphocyte responses
US7507542B2 (en) * 2001-05-08 2009-03-24 Ucb Sa Method for regulating immune function using the FOXP3 protein
DK2261249T3 (en) 2002-09-12 2015-02-16 Oncotherapy Science Inc KDR peptides and vaccines comprising the same
GB0417430D0 (en) 2004-08-05 2004-09-08 Uc3 A novel HPV vaccine comprising peptides from host cell proteins
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Ｃｘａｄｒｌ１またはｇｃｕｄ１タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
WO2006077941A1 (ja) * 2005-01-19 2006-07-27 Keio University 癌ワクチン

Also Published As

Publication number Publication date
BRPI0720794A2 (pt) 2014-03-11
JP5339375B2 (ja) 2013-11-13
AU2007340834B2 (en) 2013-02-28
EP2114987A1 (en) 2009-11-11
MX2009007261A (es) 2009-11-11
CN101641369B (zh) 2014-10-22
EP2481748A3 (en) 2012-10-24
RU2473557C2 (ru) 2013-01-27
TW200835516A (en) 2008-09-01
EP2481748A2 (en) 2012-08-01
JP2010514669A (ja) 2010-05-06
RU2009129531A (ru) 2011-02-10
EP2114987A4 (en) 2010-07-21
CA2674365A1 (en) 2008-07-10
CN101641369A (zh) 2010-02-03
WO2008081581A1 (en) 2008-07-10
TWI441648B (zh) 2014-06-21
SG177199A1 (en) 2012-01-30
US20100092501A1 (en) 2010-04-15
AU2007340834A1 (en) 2008-07-10
US8563516B2 (en) 2013-10-22
IL199622A0 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
JP5320544B2 (ja) Ｔｅｍ８ペプチドおよびそれを含むワクチン
JP5640262B2 (ja) Ｃｄｃａ１エピトープペプチドおよびそれを含むワクチン
US8617562B2 (en) FOXM1 peptides and immunogenic compositions containing them
KR20110063456A (ko) Ｉｎｈｂｂ 에피토프 펩티드 및 이를 포함하는 백신
JP5339375B2 (ja) Ｆｏｘｐ３ペプチドワクチン
RU2496787C2 (ru) Пептиды эпитопов mybl2 и содержащие их вакцины
JP2011523937A (ja) Ｉｑｇａｐ３エピトープペプチドおよびそれを含むワクチン
KR20110117112A (ko) Ｃ１ｏｒｆ５９ 펩티드 및 이를 포함하는 백신
US9745343B2 (en) Method of inducing an immune response by administering WDRPUH epitope peptides
HK1174337A (en) Foxp3 peptide vaccine

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090724

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20121214

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140326

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20141024

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20140326

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20141120

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20141024

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20150107

Appeal identifier: 2014101007160

Request date: 20141120

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20141120

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20141120

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20140530

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20121214

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20150107

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20141224

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee